Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelsey N Schafer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|October 27, 2010
Pseudophosphorylation of tau protein directly modulates its aggregation kineticsEdward Chang, Sohee Kim, Kelsey N Schafer, et al.
Neuroimage|January 26, 2012
Selectivity requirements for diagnostic imaging of neurofibrillary lesions in Alzheimer's disease: a simulation studyKelsey N Schafer, Sohee Kim, Anastasios Matzavinos, et al.
The Journal of Biological Chemistry|September 28, 2013
Structural determinants of Tau aggregation inhibitor potencyKelsey N Schafer, Katryna Cisek, Carol J Huseby, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Research towards tau imagingJordan R Jensen, Katryna Cisek, Kristen E Funk, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitorsKelsey N Schafer, Dhiraj P Murale, Kibong Kim, et al.
Biophysical Chemistry|October 18, 2012
Ligand electronic properties modulate tau filament binding site densityKatryna Cisek, Jordan R Jensen, Nicolette S Honson, et al.
The Biochemical Journal|May 30, 2014
Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensityKristen E Funk, Stefani N Thomas, Kelsey N Schafer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|October 27, 2010
Pseudophosphorylation of tau protein directly modulates its aggregation kineticsEdward Chang, Sohee Kim, Kelsey N Schafer, et al.
Neuroimage|January 26, 2012
Selectivity requirements for diagnostic imaging of neurofibrillary lesions in Alzheimer's disease: a simulation studyKelsey N Schafer, Sohee Kim, Anastasios Matzavinos, et al.
The Journal of Biological Chemistry|September 28, 2013
Structural determinants of Tau aggregation inhibitor potencyKelsey N Schafer, Katryna Cisek, Carol J Huseby, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Research towards tau imagingJordan R Jensen, Katryna Cisek, Kristen E Funk, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2011
Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitorsKelsey N Schafer, Dhiraj P Murale, Kibong Kim, et al.
Biophysical Chemistry|October 18, 2012
Ligand electronic properties modulate tau filament binding site densityKatryna Cisek, Jordan R Jensen, Nicolette S Honson, et al.
The Biochemical Journal|May 30, 2014
Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensityKristen E Funk, Stefani N Thomas, Kelsey N Schafer, et al.
Pageof 1